Takeda's innovative drug Ozezue in the field of neuroscience has been approved in China.

On July 23, according to the official WeChat account of "Takeda China," Takeda's innovative drug Ozempic in the field of neuroscience has officially received approval from the National Medical Products Administration for the treatment of 1 type of narcolepsy patients aged 16 and above. China has thus become the first market in the world to approve the use of Ozempic.